Methylprednisolone Recruiting Phase 3 Trials for Novel Coronavirus Infectious Disease (COVID-19) / Traumatic lung injury Treatment

IndicationsStatusPurposePhase
RecruitingTreatment3
clinicaltrials.gov IdentifierTitleDrugs
NCT04341038Clinical Trial to Evaluate Methylprednisolone Pulses and Tacrolimus in Patients With COVID-19 Lung Injury